U.S. Medicines Regulator Will Decide Whether to Fully Approve the Pfizer Covid Vaccine by January 2022
America's medicines regulator will decide on whether to fully approve the use of the Pfizer Covid Vaccine – currently only granted emergency use authorisation – in the U.S. for those aged 16 and over by January 2022.